The virulent influenza virus clone 7a produced a greater level of apoptosis in MDCK cells compared with the attenuated strain A/Fiji. In both cases, apoptosis could be partially blocked by treatment with three anti-neuraminidase compounds [4-amino-(GR121158A) and 4-guanidino-(GG167 ; Zanamivir) 2,3-dehydro-N-acetylneuraminic acid and 2,3-dehydro-2-deoxy-N-acetylneuraminic acid (DANA)] when they were given to cells during the virus attachment/entry phase, but not subsequent to this phase. In contrast, GG167, which does not enter cells, did not affect the numbers of infected cells and, in addition, acted late in the infection cycle to inhibit virus yields. Clone 7a neuraminidase was more active than A/Fiji neuraminidase when fetuin was used as the substrate. Similar differences in activity between the two viruses were seen when α-2,6 sialyl lactose was used as a substrate, but not with α-2,3 sialyl lactose. No sequence differences in the enzyme active site of the two neuraminidases were observed, indicating that differences in neuraminidase specificity and activity may be dictated by other residues. These results suggest that neuraminidase plays some role in the induction of apoptosis and that it acts prior to or during virus entry. However, apoptosis was considerably reduced when UV-irradiated virus, which retains 75 % of its neuraminidase activity, was used. In addition, ammonium chloride, used to prevent virus entry, reduced virus-induced apoptosis. Amantadine, which inhibits virus uncoating, also inhibited apoptosis induced by the amantadine-sensitive strain A/Udorn/307/72 (H3N2), but not the amantadine-resistant clone 7a. Hence, one or more intracellular processes are also involved in influenza virus-induced apoptosis.
Introduction
Influenza virus induces apoptosis or programmed cell death in a number of cell types including HeLa, MDCK, Vero, monocytes and macrophages (Fesq et al., 1994 ; Govorkova et al., 1996 ; Hinshaw et al., 1994 ; Lowy & Dimitrov, 1997 ; Price et al., 1997 b ; Takizawa et al., 1993) . The mechanisms involved are unclear but, in HeLa cells, Fas is believed to be an important infected cells and virus yields were similar for both viruses, the virus inducer of apoptosis may differ in identity or effectiveness for the two viruses.
In this paper we provide further evidence to support the role of influenza virus neuraminidase as an inducer of apoptosis by examining, in this system, compounds which specifically inhibit influenza virus neuraminidase activity. The three antineuraminidase compounds examined were 4-amino-(GR121158A) and 4-guanidino-(GG167) 2,3-dehydro-Nacetylneuraminic acid and 2,3-dehydro-2-deoxy-N-acetylneuraminic acid (DANA) (Ryan et al., 1995 ; Woods et al., 1993) . We also report that strains A\Fiji and clone 7a differ in their neuraminidase activity and in the specificity of their active site. Also described are experiments with UV-irradiated virus and ammonium chloride or amantadine treatment of infected cells, which were suggested by the results with the antineuraminidase compounds.
Methods
Viruses and their titrations. The virus strains (A\Fiji and clone 7a), the production of virus stocks in fertile hen eggs and their titration in eggs and egg-bits have been described previously (Price et al., 1997 b) . Titration in Madin-Darby canine kidney (MDCK) cells followed standard protocols (von Itzstein et al., 1993) . A\Udorn\307\72 (H3N2), A\Singapore\1\57 (H2N2) and B\Victoria\102\85 were obtained from A. Douglas (National Institute for Medical Research, London, UK). Seed stocks and working stocks were prepared as described previously for other influenza viruses (Sweet et al., 1974) .
High titre stocks of purified virus. These were prepared as previously described .
UV-inactivation of viruses. Viruses purified as described above were inactivated by irradiation with UV light as described previously (Price et al., 1997 b ; Pickering et al., 1992) .
Determination of the percentage of apoptotic and infected cells. The number of apoptotic cells were determined by acridine orange or propidium iodide staining as previously described (Price et al., 1997 b) and the number of infected cells were determined by fluorescence microscopy using monoclonal antibody to the nucleoprotein of the X-31 (H3N2) strain of influenza virus (Price et al., 1997 b) .
Treatment of infected cells with anti-neuraminidase compounds. Two compounds, GG167 [4-guanidino-2,3-dehydro-Nacetylneuraminic acid (4-guanidino-Neu5Ac2en) ; Zanamivir] and GR121158A [4-amino-2,3-dehydro-N-acetylneuraminic acid (4-aminoNeu5Ac2en)], were kindly supplied by R. J. Fenton (GlaxoWellcome Research and Development, Stevenage, UK) ; 2,3-dehydro-2-deoxy-Nacetylneuraminic acid (DANA) was purchased from Sigma. MDCK cells were seeded into 48-well flat-bottomed plates containing 10 mm coverslips and allowed to become confluent. Monolayers were washed twice with warmed Dulbecco's A PBS (pH 7n3), and 100 µl virus suspension, diluted in PBS to give 10 50 % egg infectious dose (EID &! ) per cell and containing 500 µg\ml compound (1n55 mM for GG167, 1n71 mM for GR121158A and 1n72 mM for DANA), was added. After 60 min at 37 mC, cells were washed three times in warmed PBS to remove unattached virus, and maintenance medium containing 500 µg\ml GG167, GR121158A or DANA, or maintenance medium alone was added. The cells were then incubated at 37 mC for a further 23 h. Different variations of this procedure are described in Results.
Effect of time of GG167 addition on its antiviral activity.
MDCK cells in six-well tissue culture plates were washed twice with warmed PBS and inoculated with 300 µl A\Singapore\1\57 (H2N2) or B\Victoria\102\85 (m.o.i. 1 p.f.u. per cell) diluted in serum-free Eagle's minimum essential medium (EMEM) containing 2 µg\ml TPCK-treated trypsin (Worthington Biochemical). At 1, 2, 4, 6, 8, 10, 12, 15, the medium was removed and replaced with warmed EMEM containing 2 µg\ml TPCK-treated trypsin and 10 µM GG167. This concentration was chosen to give 99 % inhibition of virus yield. Infected but otherwise untreated cell controls were included in each assay. After incubation at 37 mC in 5% CO # \air for 48 h, 1 ml samples of supernatant medium were removed from each well and titrated for infectivity in MDCK cells.
Measurement of cellular uptake of GG167. Confluent MDCK cells in six-well tissue culture plates were washed in PBS and then inoculated with 1 p.f.u. per cell of A\Singapore\1\57 (H2N2) influenza virus. Control wells were mock-infected. After 1 h incubation at room temperature the plates were overlaid with 2 ml defined cell culture medium (DCCM-1, Biological Industries) supplemented with 2 µg\ml TPCK-treated trypsin, containing the required amount of radioactively labelled compound. Both "%C-labelled GG167 and 2-deoxy-D-[1-"%C]-glucose, used as a control, were used at a final concentration of 5 µM. This represented 2n2 µCi GG167 and 1 µCi 2-deoxy-D-[1-"%C]-glucose. The plates were incubated at 37 mC in 5% CO # \air for 4 h, at which time the overlay medium was decanted and collected and the cells were washed six times in PBS before being detached by scraping, resuspended in PBS and disrupted by five freeze-thaw cycles. All samples were then centrifuged at 1000 r.p.m. in a bench centrifuge and the resultant pellet washed three times in PBS. The pellet was then treated with 0n5 % SDS (w\v) for 30 min at room temperature. Samples (50 µl) were counted for radioactivity in 4 ml scintillation fluid in an LKB Rackbeta scintillation counter.
Assay of viral neuraminidase activity. The standard WHO assay using fetuin as substrate was used (Aminoff, 1961 ; Aymard-Henry et al., 1973) except that at the end of the assay 200 µl of the formed chromophore was added to a 96-well microtitre plate and absorbance (A) was read using a multiplate reader with a wavelength of 540 nm and a path length of 0n5 cm. Enzyme activities are expressed as µmol\l Nacetyl neuraminic acid (NANA) released per min, calculated from a standard curve of NANA concentration against A (y l 0n702x).
Examination of substrate specificity of clone 7a and A/Fiji. Sialyl lactoses with α-2,3 or α-2,6 linkages between the sialic acid residue and lactose were used as substrates. Purified influenza virus at a concentration of 2 µg viral protein\ml was added to a reaction mixture containing 32n5 mM 2-(N-morpholino)ethane sulphonic acid, 4 mM CaCl # , 1 mM MgSO % , 1 mM β-nicotinamide adenine dinucleotide (NAD + , from yeast ; Sigma), 2n25 U\ml β-galactosidase (grade VIII purified from E. coli ; Sigma), 10 U\ml glucose dehydrogenase (from Bacillus megaterium ; Sigma) and 0n1 mM α-2,3 or α-2,6 sialyl lactose (Sigma) contained in a 96-well flat-bottomed microtitre plate in a final volume of 200 µl. The plate was incubated at 37 mC. During the reaction sialyl lactose is cleaved by neuraminidase to sialic acid and lactose, the latter being converted to galactose and glucose by β-galactosidase. Glucose is reduced by glucose dehydrogenase in the presence of NAD + to give NADH which is read at 340 nm. Reactions were read at intervals in an ELISA plate reader. Enzyme activities are expressed as µmol\l lactose released per min, calculated from a standard curve of lactose concentration against A (y l 2n457x).
Sequence of clone 7a and A/Fiji neuraminidases. Virion RNA, extracted from purified virus using phenol : diethyl ether extraction BDI Influenza virus neuraminidase and apoptosis Influenza virus neuraminidase and apoptosis followed by ethanol precipitation, was reverse transcribed with avian myeloblastosis virus reverse transcriptase using primers for the 3h end of segment 6 (neuraminidase) of A\Chile\1\83 (H1N1) (GCAGGAGTT-TAAAATGAATCCAAAT) or A\Northern Territories\60\68 (H3N2) (GCAGGAGTGAAAATGAATCCAAATC) for A\Fiji and clone 7a, respectively (Schreier et al., 1988 ; Bentley & Brownlee, 1982) . Doublestranded (ds) DNA was then produced using Taq polymerase and primers specific for the 5h end of the neuraminidase gene ; CAACGGACTA-CTTGTCAATGGTGA and CTAAAATTGCGAAAGCTTATATAG for A\Fiji and clone 7a, respectively (Schreier et al., 1988 ; Bentley & Brownlee, 1982) . Segment 6 from clone 7a and A\Fiji was amplified by PCR as described (Adeyfa et al., 1994) . Following purification using the Wizard PCR preps DNA purification system (Promega) or Microspin S-400HR columns (Pharmacia Biotech), the PCR products were either sequenced directly or following cloning into a pCR 2.1 vector and INVαF-competent cells using the original TA cloning kit version F (Invitrogen). DNA was then sequenced using an ABI PRISM automated gene sequencer with the PE Applied Biosystems four-dye technology.
Treatment of infected cells with ammonium chloride. MDCK cells were seeded into 48-well flat-bottomed plates containing 10 mm coverslips and allowed to become confluent. Monolayers were washed twice in warmed PBS and growth medium containing 20 mM NH % Cl was added. After 60 min incubation at 37 mC, the medium was removed and PBS containing 10 EID &! virus per cell and 20 mM NH % Cl added. After 60 min at 37 mC, cells were washed three times in warmed PBS, maintenance medium containing 20 mM NH % Cl was added and the cells were incubated at 37 mC for a further 23 h.
Treatment of infected cells with amantadine. MDCK cells were seeded into 48-well flat-bottomed plates containing 10 mm coverslips and allowed to become confluent. Monolayers were washed twice with warmed PBS and 100 µl virus suspension, diluted in PBS to give 10 EID &! per cell and containing 0n3, 0n4 mM or 10 µM amantadine hydrochloride, was added. After 60 min at 37 mC, cells were washed three times in warmed PBS, and maintenance medium containing the same concentration of amantadine was added. The cells were then incubated at 37 mC for a further 23 h.
Results

Differential apoptosis produced by strains A/Fiji and clone 7a
Previous results on clone 7a and A\Fiji (Price et al., 1997 b) were confirmed using an inoculum of 10 EID &! per cell. In two experiments using three replicates (n l 3) per sample the levels of apoptosis 24 h after infection were : 89n0 % (SD 5n8) and 97n6 % (SD 0n3) for clone 7a ; 10n4 % (SD 6n4) and 9n4 % (SD 2n5) for A\Fiji ; and 0n3 % (SD 0n3) and 0n5 % (SD 0n3) for controls.
The inhibitory effect of GR121158A or GG167 on apoptosis induced by clone 7a and A/Fiji
MDCK cells infected with 10 EID
&! per cell of clone 7a or A\Fiji were treated with 500 µg\ml GR121158A or GG167. The drug was added at the time of addition of virus, and throughout the subsequent incubation until the cells were examined for apoptosis by nuclear staining at 24 h p.i. (i.e. throughout the 24 h incubation as shown in Table 1 ) ; the latter was found to be the optimal time-point for sampling in preliminary experiments. Uninfected control cells were also examined in the presence and absence of the drug. The percentage of cells exhibiting apoptosis following infection with clone 7a was significantly decreased by treatment with GR121158A or GG167. Similarly, the smaller percentage of apoptotic cells produced by A\Fiji was also reduced by treatment with the drugs. With both viruses apoptosis was not completely abrogated by the anti-neuraminidase compounds even though the neuraminidase activity of both viruses was completely inhibited by 200 µg\ml GR121158A [enzyme activity of 5i10' EID &! clone 7a in the presence and absence of GR121158A was 0n08 (SD 0n03 ; n l 2) and 1n29 (SD 0n40 ; n l 2) µmol\l NANA released per min, respectively, and for 5i10' EID &! A\Fiji it was 0n04 (SD 0n01 ; n l 2) and 0n4 (SD 0n06 ; n l 2), respectively] or GG167 [enzyme activity for clone 7a in the presence and absence of GG167 was 0n05 (SD 0n03 ; n l 2) and 1n29 (SD 0n4; n l 2) µmol\l NANA released per min, respectively, and for A\Fiji it was 0n04 (SD 0n01 ; n l 2) and 0n4 (SD 0n06 ; n l 2), respectively].
The results in Table 1 also show that adding the compounds for only the attachment period was as effective as having them present throughout the incubation period. Table 1 also shows the results of adding the antineuraminidase compounds after virus attachment had taken place. The lack of inhibitory effect on apoptosis clearly indicates that the initial 1 h period is the crucial phase for the action of the compounds.
Lack of inhibition of apoptosis when antineuraminidase compounds were added after the period of virus attachment
Inhibition of influenza virus-induced apoptosis by DANA
Both 4-guanidino-2,3-dehydro-N-acetylneuraminic acid (GG167) and 4-amino-2,3-dehydro-N-acetylneuraminic acid (GR121158A) contain basic residues and could thus act as weak bases (like NH % Cl, see later) to inhibit apoptosis. This is unlikely due to their different optimal times of action (see above and later) and further evidence that this was not the case is provided using DANA (2,3-dehydro-2-deoxy-N-acetylneuraminic acid), which has no basic residues yet still inhibited influenza virus-induced apoptosis (Table 1) and at 200 µg\ml completely inhibited neuraminidase activity [enzyme activity for 5i10' EID &! clone 7a in the presence and absence of DANA was 0n08 (SD 0n0; n l 2) and 0n84 (SD 0n06 ; n l 2) µmol\l NANA released per min, respectively].
Effect of time of addition of GG167 on its antiviral activity
As expected from previously published studies on the mode of action of viral neuraminidase (Liu et al., 1995 ; Palese BDJ & Compans, 1976 ; Palese et al., 1974 ) the percentage of infected cells was not significantly decreased in the presence of GG167. A total of 99n6 % (SD 0n11 ; n l 3) of cells were infected in the absence of compound whereas 99n7 % (SD 0n11 ; n l 3) were infected in its presence when cells were treated with compound for the 1 h attachment period only. The situation was similar when cells were treated with compound for the 23 h after the attachment period [99n7 % (SD 0n11 ; n l 3) and 99n6 % (SD 0n6; n l 3) cells were infected in the absence and presence of compound, respectively]. This suggested that the drugs had little or no effect on virus attachment, entry, RNA replication or protein synthesis. This was confirmed in a study which examined the effect of time of addition of compound on its antiviral activity. When GG167 was added at early times post-infection (1 and 2 h p.i.) it almost completely inhibited virus replication, whilst addition between 6 and 12 h p.i. considerably reduced virus yields (Table 2) . In contrast, when compound was added 15 h p.i. or later, yields were similar to control cultures. These results confirm previous observations that neuraminidase inhibitors act late in the infection cycle.
Lack of entry of GG167 into uninfected or infected cells
The majority [99n7% (SD 0; n l 2) and 99n6 % (SD 0n28 ; n l 2), respectively] of total input radioactivity associated with the "%C-labelled GG167 added to influenza virus-infected or uninfected cells was recoverable in the medium or subsequent washes. Similarly, little radioactivity was found in the cell pellets [0n78 % (SD 0n18 ; n l 2) and 0n78 % (SD 0n04 ; n l 2), respectively] of infected and uninfected cells. In contrast, 5n49 % (SD 1n43 ; n l 2) and 8n17 % (SD 6n8; n l 2) total input "%C-labelled glucose was found in infected and uninfected cells, respectively, while yields from supernatants and washes were 91n5 % (SD 4n9; n l 2) and 95 % (SD 2n5;
Influenza virus neuraminidase and apoptosis Influenza virus neuraminidase and apoptosis Fig. 1 . Comparison of neuraminidase activities of clone 7a and A/Fiji using α-2,3 and α-2,6 sialyl lactoses as substrates. Equal protein concentrations (2 µg/ml) of clone 7a (solid line) and A/Fiji (dashed line) were used. The absorbances recorded at time intervals were those for NADH derived from glucose liberated by the action of neuraminidase on either α-2,3 (#) or α-2,6 ($) sialyl lactose, followed by cleavage of the lactose with β-galactosidase (see Methods). Error bars show SD of the mean of two replicates at each time-point. n l 2), respectively. These results suggest that GG167 does not enter cells in significant quantity.
The neuraminidase activity of clone 7a is greater than that of A/Fiji when fetuin is used as a substrate
The neuraminidase activities of the two viruses were significantly different (P 0n05). At equal infectivities of 5i10& EID &! the enzyme activities were 0n25 (SD 0n03 ; n l 2) and 0n03 (SD 0n01 ; n l 2) µmol\l NANA released per min for clone 7a and A\Fiji, respectively, while at equal protein concentrations of 6n25 µg virus the activities were 2n1 (SD 0n04 ; n l 2) and 1n2 (SD 0n01 ; n l 2) µmol\l NANA released per min for clone 7a and A\Fiji.
The different specificities of clone 7a and A/Fiji neuraminidases
The results in Fig. 1 show that although the neuraminidases of clone 7a and A\Fiji show similar activity when α-2,3 sialyl lactose was used as a substrate, the clone 7a preparation was considerably more active than that of A\Fiji when α-2,6 sialyl lactose was used as a substrate. Neuraminidase activities for 2 µg of clone 7a and A\Fiji using α-2,3 sialyl lactose as substrate were 0n86 (SD 0n09) and 0n82 (SD 0n07) µmol\l lactose released per min, respectively and for α-2,6 sialyl lactose were 0n7 (SD 0n03) and 0n45 (SD 0n03) µmol\l lactose released per min. The neuraminidase activity of clone 7a using α-2,6 sialyl lactose as substrate was significantly greater than that for A\Fiji (P 0n01), whereas the comparison with α-2,3 sialyl lactose as substrate was not significantly different (P 0n05). Devereux et al., 1984) . Amino acid residues comprising the enzyme active site are shown in bold . Cysteine residues likely to be involved in the disulphide bridge formation are boxed ; potential glycosylation sites are underlined . Vertical lines denote amino acid identity and colons refer to conservative changes.
Amino acid sequences of clone 7a and A/Fiji neuraminidases
As with other viruses of the N1 and N2 serotypes, the amino acid compositions of the two neuraminidases showed 50n96 % similarity and 42n46 % identity. However, the amino acids comprising the enzyme active sites were conserved in both neuraminidases (Fig. 2) . A number of cysteine residues involved in disulphide bridge formation are present in both viruses (Fig. 2) , but cysteine residues 175 and 193, found in clone 7a N2, are lacking in A\Fiji N1. A number of potential glycosylation sites have been identified . These correspond to asparagine residues 86, 146 and 234 in clone 7a, and 88, 145 and 235 in A\Fiji. An additional site recognized by Varghese and colleagues is at asparagine residue 200 in clone 7a, but is absent in A\Fiji. Two other potential sites found in both viruses are at asparagine residues 61 and 70 and 63 (or 58) and 70 in clone 7a and A\Fiji, respectively. Two unique clone 7a sites occur at asparagine residues 69 and 402 and three unique A\Fiji sites are found at asparagine residues 44, 58 (or 63) and 365.
UV-inactivated viruses induce little apoptosis
When both clone 7a and A\Fiji were UV-inactivated, the amount of apoptosis was markedly decreased 24 h post- 
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* Cells were treated with (j) or without (k) 20 mM NH % Cl from 1 h prior to virus inoculation, and NH % Cl was subsequently present in the medium until 24 h p.i. (25 h total). Cells were also treated with NH % Cl for the 1 h virus attachment period and subsequent 23 h (24 h total) and for the post-attachment period only (23 h total).
† The percentage of apoptotic cells was calculated by staining for nuclear morphology (as described in Methods). Standard deviations from the mean of three replicates are shown ; at least 1000 cells were counted for each replicate.
inoculation. With inocula of 10 or 100 pg per cell ( 1000 and 10 000 EID &! infectious virus per cell, respectively) of clone 7a, levels of apoptosis were only 10n3 % (SD 4n3; n l 3) and 2n9% (SD 1n4; n l 3), respectively ; levels for A\Fiji were barely discernible [2n2 % (SD 1n1; n l 3) and 0 % (SD 0 ; n l 3), respectively]. No nucleoprotein synthesis occurred in these cells, as judged by monoclonal antibody staining (data not shown). Both haemagglutinating (data not shown) and neuraminidase activities of UV-irradiated virus [1n67 (SD 0n27 ; n l 2) and 1n23 (SD 0n06, n l 2) µmol\l NANA released per min for clone 7a and A\Fiji, respectively] were not significantly reduced (P 0n05) compared to unirradiated virus [1n69 (SD 0n04 ; n l 2) and 1n26 (SD 0n01 ; n l 2) µmol\l NANA released per min for clone 7a and A\Fiji, respectively].
Effect of ammonium chloride on virus-induced apoptosis
The above results suggested that virus replication was important for the induction of apoptosis by influenza virus. To examine this further, cells were treated with NH % Cl, which is known to prevent virus entry into cells (Jakeman et al., 1991) . Virus-infected MDCK cells were treated with 20 mM NH % Cl continuously from 60 min prior to virus inoculation until examined for apoptosis. As in previous experiments, clone 7a induced significantly more apoptosis than A\Fiji (P 0n05) in untreated cells (Table 3) . However, induction of apoptosis was severely reduced with both viruses if NH % Cl was included in the medium throughout the experimental period (i.e. 25 h ; 1 h pretreatmentj1 h virus attachment periodjsubsequent 23 h incubation ; see Methods) ( Table 3 ). The percentage of infected cells decreased from 99n6 (SD 0n6; n l 3) to 21n8 % (SD 6n21 ; n l 3) after treatment of clone 7a-infected cells with NH % Cl for 25 h. In contrast, the neuraminidase activity of clone 7a virions increased slightly but significantly (P 0n05) from 1n23 (SD 0n02) to 1n35 (SD 0n02) µmol\l NANA released per min in the presence of 20 mM NH % Cl, whereas that of A\Fiji did not change significantly (P 0n05) [0n42 (SD 0n02) and 0n34 (SD 0n02) in the presence and absence of NH % Cl, respectively]. Gradually decreasing the time of exposure to NH % Cl abrogated its effect on reduction of virus-induced apoptosis, although exposure to NH % Cl at any stage did affect the percentage of apoptotic cells (Table 3) . Treatment of infected cells for 1 h only with NH % Cl also reduced the percentage of cells infected significantly (P 0n05), but only slightly, to 94n7 % (SD 1n2; n l 3), whereas treatment for the 23 h post-attachment period had no effect (99n0 % SD 0n5; n l 3). These results suggest that inhibition or reduction of virus entry reduces apoptosis. While treatment with NH % Cl after the virus attachment period did reduce apoptosis, suggesting that NH % Cl may be anti-apoptotic, it is unlikely that this explains the considerably greater reduction in virusinduced apoptosis seen when infected cells were exposed for a further 1 h during virus attachment.
Additive action of GG167 and ammonium chloride
The above results suggested that more than one mechanism contributed to influenza virus-induced apoptosis ; GG167 acted 
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* Cells were treated with (j) or without (k) 500 µg\ml GG167 and\or 20 mM NH % Cl throughout the 24 h incubation period in both Expt 1 and Expt 2.
† The percentage of apoptotic cells was calculated by staining for nuclear morphology (as descibed in Methods). Standard deviations from the mean of three replicates in Expt 1 and six replicates in Expt 2 are shown ; at least 1000 cells were counted for each replicate.
to reduce apoptosis at the virus attachment\entry stage, whilst NH % Cl and UV-inactivation inhibited apoptosis by preventing virus replication. Support for this was provided in clone 7a cells treated with both NH % Cl and GG167, where an additive or synergistic effect was obtained (Table 4) . Clone 7a-infected cells exhibited 78-83 % apoptosis, this being reduced to 42-51 % and 13-31 %, respectively, by treatment with GG167 or NH % Cl. A further reduction to only 2-3 % apoptosis was observed when both inhibitors were present (Table 4) .
Effect of amantadine chloride on virus-induced apoptosis
Amantadine inhibits uncoating of human influenza viruses but, as shown in Table 5 , it had little effect on apoptosis induced by either clone 7a or A\Fiji. However, virus yields were unaffected by treatment with amantadine, even at doses of 10 µM (data not shown) and the percentage of infected cells was only reduced from 99n6 (SD 0n7; n l 3) to 86n0 % (SD 2n2; n l 3). Higher doses of amantadine could not be used as they induced apoptosis (data not shown). Similar results were also obtained with an inoculum of 1 EID &! per cell. It is likely that clone 7a was not inhibited by amantadine as it contains the M2 gene of A\Puerto Rico\8\34 (H1N1) (Matsuyama et al., 1980) , which is resistant to amantadine (Wharton et al., 1994) . The results suggest that the M2 protein of A\Fiji may also be resistant. An experiment with 1 EID &! per 
* Cells were treated with (j) or without (k) amantadine hydrochloride throughout the 24 h incubation period. † The percentage of apoptotic cells was calculated by staining for nuclear morphology (as descibed in Methods). Standard deviations from the mean of six replicates for 0n3 mM and three replicates for 0n4 mM and 10 µM are shown ; at least 1000 cells were counted for each replicate.
cell of A\Udorn\307\72 (H3N2) showed that this amantadine-sensitive virus induced 16n2 (SD 4n1) % apoptosis, which was reduced to 3n1 (SD 0n4) % on treatment with 0n3 mM amantadine. Again similar results were obtained with an inoculum of 10 EID &! per cell. Thus, inhibition of virus uncoating with amantadine also reduces apoptosis.
Discussion
It is clear from the above results that neuraminidase is involved in induction of apoptosis by influenza viruses. First, three anti-neuraminidase compounds partially abrogate apoptosis during infection of MDCK cells without affecting numbers of infected cells. Second, the differential abilities of clone 7a and A\Fiji to induce apoptosis is reflected in differences in the amounts of neuraminidase activity in the two strains, and differences in the specificity of the two enzymes.
The results also show that the action of neuraminidase in promoting apoptosis occurs at, or shortly before, virus binding and entry to the cells (Table 1) . This is rather surprising as a considerable body of evidence suggests that the role of the viral neuraminidase during infection is not in virus attachment, entry, replication, assembly or budding, but in preventing aggregation of virus particles at the cell surface to allow further infection of uninfected cells (Liu et al., 1995 ; Palese & Compans, 1976 ; Palese et al., 1974) . When neuraminidase activity was abrogated by antibody (Compans et al., 1969) , inhibitors such as FANA (2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid) (Palese & Compans, 1976) and GG167 (this communication), or temperature-sensitive mutation (Palese et al., 1974) , virus particles attached to each other and aggregated at the cell surface. A neuraminidase-deficient virus behaved similarly (Liu et al., 1995) . In our studies on the timing of the antiviral effect of the compounds on virus replication, the compounds acted late in the infection cycle and did not affect virus replication as judged by numbers of infected cells ; also, the experiments were performed under single cycle conditions, where further rounds of replication were not applicable. In addition, use of radiolabelled GG167 showed that it did not enter cells and that it must therefore act extracellularly. In the case of its inhibition of virus replication this would be newly emerged virus particles on the cell surface. The implication of this is that the target for neuraminidase inhibition of apoptosis must also be on the cell surface. A candidate for this target is TGF-β. This is synthesized as a latent precursor present on cell surfaces. Active TGF-β is released from the C terminus of the latent form following proteolytic cleavage by a furin-like protease (Blanchetta et al., 1997) . This activation probably occurs at the cell surface where the pro-TGF-β segments are retained and active TGF-β is released into the medium (Gitelman & Dernyck, 1994) . Latent TGF-β has three glycosylation sites (Brunner et al., 1988) , and removal of oligosaccharides may facilitate proteolytic cleavage or enhance the release of TGF-β. This is conceptually similar to cleavage of influenza haemagglutinin into the fusion-competent HA " and HA # domains following removal of oligosaccharide side chains around the cleavage site (Kawaoka, 1991) . Recent studies have shown that TGF-β may be activated by influenza virus neuraminidase and, once active, is capable of inducing apoptosis in MDCK cells (Schultz-Cherry & Hinshaw, 1996) .
The differences in neuraminidase activities of clone 7a and A\Fiji are interesting. It is possible that different quantities of neuraminidase are incorporated into virions of clone 7a and A\Fiji, but this does not explain the difference in substrate specificity observed between the two strains. A\Fiji has lower enzyme activity than clone 7a for fetuin and a similar activity to clone 7a against α-2,3 sialyl lactose, which is surprising because fetuin contains α-2,3 sialyl linkages. Clone 7a neuraminidase is clearly more active than that of A\Fiji for α-2,6 sialyl linkages (Fig. 1) . The different activity of the neuraminidase from A\Fiji for the α-2,3 sialyl linkages of the smaller molecular weight sialyl lactose and the larger molecular weight glycoprotein fetuin do not reflect neuraminidase ' stalk ' length as these are similar in both neuraminidases (Table 3) . Viruses with ' stubby stalks ' have been shown to elute more slowly from erythrocytes (Els et al., 1985) . The amino acid residues comprising the enzyme active site are also conserved in both neuraminidases, but there are differences in the number of cysteine residues (two are missing in A\Fiji N1) and asparagine residues, which could affect the conformation of the active site and contribute to neuraminidase activity and specificity. These changes are conserved in other N1 neuraminidases. We are currently examining other N1 viruses for enzyme activity and specificity and for ability to induce apoptosis.
The levels of anti-neuraminidase compounds used in these experiments (1n51, 1n71 and 1n72 mM for GG167, GR121158A and DANA, respectively) were sufficient to eliminate all neuraminidase activity of the inoculum (Gubareva et al., 1996 ; this communication) . Indeed, the levels were well above their IC &! values (the concentration required to reduce plaque formation in MDCK cells by 50 %) which are 0n014 µM and 1n5 µM for GG167 and GR121158A, respectively, for A\ Singapore\1\57 (H2N2) (von Itzstein et al., 1993) . However, some apoptosis still occurred despite this neutralization of neuraminidase activity (Table 1) . Therefore, neuraminidase activation of TGF-β cannot be the sole mechanism for apoptosis induced by influenza virus. An intracellular mechanism probably also contributes to apoptosis as inhibition of virus replication inhibited apoptosis. Thus, UV-inactivated virus did not induce apoptosis and treatment of virus-infected cells with NH % Cl abrogated apoptosis (Table 4) . Also, amantadine inhibited apoptosis induced by A\Udorn\307\72 ; it inhibited clone 7a-induced apoptosis only poorly, presumably as this virus contains the M2 gene from the amantadine-resistant A\Puerto Rico\8\34 parent (Wharton et al., 1994) . It is possible that some early aspect of replication is also needed for neuraminidase to manifest its apoptotic activity because UVinactivated virus retained much, if not all, of its neuraminidase activity, but showed little if any ability to induce apoptosis. It thus seems likely that more than one mechanism, and hence virus component, is contributing since NH % Cl and GG167 were at least additive and possibly synergistic when added together to virus-infected cells (Table 5) .
The nature of this second pro-apoptotic pathway is unclear. One possibility is that it may involve the interferon-induced, dsRNA-activated protein kinase (PKR) (Takizawa et al., , 1996 . PKR activation follows its interaction with dsRNA and results in a cascade of effects including activation of transcription factors NF-κB and NF-IL6 (Jacobs & Langland, 1996) . NF-IL6 regulates the pro-apoptotic transmembrane protein Fas (Wada et al., 1995) , a member of the tumour necrosis factor\nerve growth factor receptor family that induces the cell to become apoptotic when cross-linked by its ligand (FasL). PKR inhibitors prevent expression of Fas and cells transfected with inactive mutant PKR resist influenza virus-induced apoptosis (Takizawa et al., 1996) . In contradiction to this, recent preliminary evidence suggests that viral NS1 alone can induce apoptosis yet it inhibits PKR activation (Lu et al., 1995) and a mutation in the RNA-binding domain of NS1 abrogates its ability to induce apoptosis (Schultz-Cherry et al., 1998) .
Elucidation of the pathways of influenza virus-induced apoptosis is not merely of academic interest. These pathways may be involved in stimulation of the constitutional symptoms of influenza as well as damage to the respiratory tract (which BEE may promote secondary bacterial infections). Cytokine release from infected cells during influenza virus-induced apoptosis, brought about either directly (TGF-β activation by neuraminidase) or indirectly (via de novo gene transcription following NF-κB and NF-IL6 activation by PKR) is likely to be critical in the severity of symptoms and the effectiveness of the host inflammatory response. For example, NF-κB regulates interferon-β, interleukin (IL)-1β, IL-6, IL-8, IL-1 receptor antagonist (IL-1ra), macrophage inflammatory protein 1α and β, and tumour necrosis factor expression (Baldwin, 1996 ; Lenardo & Baltimore, 1989 ; McDonald et al., 1997) , whilst NF-IL6 also regulates IL-6, IL-8 and granulocyte-and granulocyte\macrophage colony stimulating factors (Jamaluddin et al., 1996 ; Wada et al., 1995) , all of which have important regulatory roles in the inflammatory response. In addition, active IL-1β (a potent pro-inflammatory cytokine and endogenous pyrogen) is released from pro-IL-1β by IL-1β-converting enzyme (ICE), which is an intracellular protease known to be activated during apoptosis (Kumar, 1995) . Also, once activated and bound to its receptors, TGF-β from infected cells may trigger transcription of further genes involved in the inflammatory response (Knaus & Lodish, 1994) . Overall, this suggests that the symptoms of influenza virus infection may be ameliorated by the use of treatments which inhibit virusinduced apoptosis, for example the anti-neuraminidase compounds described in this paper.
